Drug preparation and Clinical Study of Hrudayarnavaras its effect on excess Cholesterol
Phase 4
Not yet recruiting
- Conditions
- Health Condition 1: null- HyperLipidemia (excess Cholestrol)
- Registration Number
- CTRI/2017/05/008600
- Lead Sponsor
- Dr M Srinivas Naik
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
Hyperlipidemia
Angio graphically documented Coronary artery disease Radiological confirmation through Angiogram Doppler studies etc
Abnormalities present in ECG Echocardiography Stress test etc
Exclusion Criteria
Age below 35 years
Recent MI less than three months
Patients with conduction problem
Patient with uncontrolled hypertension
Unstable Angina
Serious concomitant disease of liver and or kidney.Any malignancy Undergoing treatment for any other serious illness
Pregnant women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduced levels of Lipid Profiles Arrest of the progress of condition into atherosclerosis <br/ ><br>c)Prevention of complications like CAD, MI and CVA etc. <br/ ><br>Timepoint: Reduced levels of Lipid Profiles <br/ ><br>Arrest of the progress of condition into atherosclerosis <br/ ><br>c)Prevention of complications like CAD, MI and CVA etc. <br/ ><br>
- Secondary Outcome Measures
Name Time Method improvement generalcondition of the patient and can to their work easilyTimepoint: treatment period 90 days followup treatment for every 30 days;To reduce the serum lipid levelsTimepoint: 6 months